Tert-butyl (3S,4S)-3-amino-4-(3,4-difluorophenyl)piperidine-1-carboxylate;4-(4-cyclopropyl-1-methylpyrazol-5-yl)-N-[(3S,4S)-4-(3,4-difluorophenyl)piperidin-3-yl]-2-fluorobenzamide;4-(4-cyclopropyl-1-methylpyrazol-5-yl)-2-fluorobenzoic acid
C55H60F6N8O5 — CID 158875512
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl (3S,4S)-3-amino-4-(3,4-difluorophenyl)piperidine-1-carboxylate;4-(4-cyclopropyl-1-methylpyrazol-5-yl)-N-[(3S,4S)-4-(3,4-difluorophenyl)piperidin-3-yl]-2-fluorobenzamide;4-(4-cyclopropyl-1-methylpyrazol-5-yl)-2-fluorobenzoic acid
Tert-butyl (3S,4S)-3-amino-4-(3,4-difluorophenyl)piperidine-1-carboxylate;4-(4-cyclopropyl-1-methylpyrazol-5-yl)-N-[(3S,4S)-4-(3,4-difluorophenyl)piperidin-3-yl]-2-fluorobenzamide;4-(4-cyclopropyl-1-methylpyrazol-5-yl)-2-fluorobenzoic acid (PubChem CID 158875512) has the molecular formula C55H60F6N8O5 and a molecular weight of 1027.12 g/mol. Its IUPAC name is tert-butyl (3S,4S)-3-amino-4-(3,4-difluorophenyl)piperidine-1-carboxylate;4-(4-cyclopropyl-1-methylpyrazol-5-yl)-N-[(3S,4S)-4-(3,4-difluorophenyl)piperidin-3-yl]-2-fluorobenzamide;4-(4-cyclopropyl-1-methylpyrazol-5-yl)-2-fluorobenzoic acid.
Molecular Properties
| Compound Name | Tert-butyl (3S,4S)-3-amino-4-(3,4-difluorophenyl)piperidine-1-carboxylate;4-(4-cyclopropyl-1-methylpyrazol-5-yl)-N-[(3S,4S)-4-(3,4-difluorophenyl)piperidin-3-yl]-2-fluorobenzamide;4-(4-cyclopropyl-1-methylpyrazol-5-yl)-2-fluorobenzoic acid |
|---|---|
| PubChem CID | 158875512 |
| Molecular Formula | C55H60F6N8O5 |
| Molecular Weight | 1027.12 g/mol |
| Exact Mass | 1026.46 |
| IUPAC Name | tert-butyl (3S,4S)-3-amino-4-(3,4-difluorophenyl)piperidine-1-carboxylate;4-(4-cyclopropyl-1-methylpyrazol-5-yl)-N-[(3S,4S)-4-(3,4-difluorophenyl)piperidin-3-yl]-2-fluorobenzamide;4-(4-cyclopropyl-1-methylpyrazol-5-yl)-2-fluorobenzoic acid |
| SMILES | CC(C)(C)OC(=O)N1CC[C@@H](c2ccc(F)c(F)c2)[C@H](N)C1.Cn1ncc(C2CC2)c1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)c(F)c1.Cn1ncc(C2CC2)c1-c1ccc(C(=O)O)c(F)c1 |
| InChI | InChI=1S/C25H25F3N4O.C16H22F2N2O2.C14H13FN2O2/c1-32-24(19(12-30-32)14-2-3-14)16-4-6-18(21(27)11-16)25(33)31-23-13-29-9-8-17(23)15-5-7-20(26)22(28)10-15;1-16(2,3)22-15(21)20-7-6-11(14(19)9-20)10-4-5-12(17)13(18)8-10;1-17-13(11(7-16-17)8-2-3-8)9-4-5-10(14(18)19)12(15)6-9/h4-7,10-12,14,17,23,29H,2-3,8-9,13H2,1H3,(H,31,33);4-5,8,11,14H,6-7,9,19H2,1-3H3;4-8H,2-3H2,1H3,(H,18,19)/t17-,23+;11-,14+;/m00./s1 |
| InChIKey | JCJNAISJLVWJRE-FFOHSROBSA-N |
| XLogP | 10.08 |
| TPSA | 169.63 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 74 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1027.12 |
| LogP ≤ 5 | 10.08 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158875512 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.